A 9-year-old male patient with medulloblastoma underwent surgical resection of the tumor and then began adjuvant treatment with proton beam therapy to his occiput and spine 5 days a week, as well as weekly vincristine infusions. During each proton beam therapy session, a custom-molded thermoplastic mask made of polyester resin was placed over the patient's face and neck and bolted to the treatment table to immobilize him (Figure 1). Fifteen days after initiating proton beam therapy, the patient developed a pruritic, erythematous, edematous rash that started on his ears and neck and spread to involve his cheeks and forehead (Figure 2A,B). The rash was sharply demarcated on the face and anterior neck and did not involve the scalp, back, or any other areas of the body. It was non-tender and minimally responsive to antihistamines. The rash flared after each proton beam therapy session. The rash raised concern for radiation dermatitis or ACD. However, radiation dermatitis was ruled out because the rash spared the occiput and spine, which were directly irradiated, and was limited to the areas of the face and neck that contacted the thermoplastic mask during treatment. A clinical diagnosis of ACD to the thermoplastic mask was made. The thermoplastic mask used during the patient's radiation therapy was a KLARITY GREEN™ mask (RG-BHM-3242, Klarity Medical Products, LLC, Heath, OH) made primarily of cured